Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
North America Frac Sand is an OTC-traded company that no longer primarily operates in frac sand; through its Voycare brand it has described itself as a telemedicine, medical tourism, and Chinese-language digital health platform focused on women's health in Asia, especially China. Company disclosures and press releases indicate services centered on connecting overseas patients to healthcare providers in areas such as oncology, in vitro fertilization, cosmetic surgery, and wellness. The company appears to have evolved through several business pivots over time, including historical frac sand and later coffee-related operations, so its current operating identity is best understood as a small, diversified microcap with a healthcare-oriented digital services story rather than a biotech drug developer. It does not appear to run a therapeutic drug pipeline, clinical-stage R&D program, or proprietary pharmaceutical platform in the conventional biotech sense. As a result, it is healthcare-related, but not a life sciences company focused on developing drugs, biologics, or medical technologies for regulatory approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North America Frac Sand.